- Commissioner Enhances FDA’s Commitment to Personalized Medicine
- Perfecting Policy on Stem Cells
- NIH and FDA Aim to Retool Regulatory Science
- DOE Leads Federal Funding for a Regional Innovation Cluster
- Certainty on the Science of Climate Change
- They’re Not Perfect Cells, But They’re Model Cells
- Genomic Medicine on the March
- President’s Budget Aims to Recharge Regional Innovation
- Event: The Science of Climate Change
- Progress in Bioethics
- The Top Science Progress Features of 2009
- Science Education Progress
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
Here’s One Big Step Toward Artificial Life
The much-anticipated creation of an organism based on genes assembled in the laboratory took a major step forward with an announcement by the J. Craig Venter Institute in Rockville, Maryland. Scientists have succeeded in synthesizing the complete genome of a bacterium, Mycoplasma genitalium. If the stitched DNA can be inserted into a cell that then replicates, it will appear to have met the criteria for the first “artificial life” form. The organism generated by this minimal genome could then be used as a modifiable platform for the manufacture of biological materials like environmentally friendly fuels or cells that can break down pollutants.
Experts on biological weapons, along with those who worry about novel threats to public health from any source, are watching these developments closely. To address concerns that the bacterium could be a pathogen, the lab disabled a gene that enables the bacteria to attach to human cells.
Reports indicate that Venter and colleagues believe the next step—using the DNA strand to govern a functional cell—could be accomplished within the year. When that happens, synthetic biology will have decisively left the arena of science fiction and could be the beginning of industries based on cellular factories.
Comments on this article
